advertisement
11.3.4 Betablocker (5)
Showing records 1 to 5
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker47868 Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
Inoue K; Noguchi K; Wakakura M; Tomita G
Clinical Ophthalmology 2011; 5: 1211-1216
47809 Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo
Hui-Hui Z; Qiu-Hua L; Zhi-Jun Y; Wei-San P; Shu-Fang N
Drug Delivery 2011; 18: 502-510
47853 Timogel((registered trademark)) vs timolol 0.5% ophthalmic solution: Efficacy, safety, and acceptance
Rolle T; Curto D; Alovisi C; Franzone M; Brogliatti B; Grignolo FM
European Journal of Ophthalmology 2011; 22: 28-33
48303 Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial
Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B; for the EMGT Group
Acta Ophthalmologica 2011; 89: 749-754
47810 Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe
Hollo G; Thelen U; Teus MA; Quaranta L; Ferkova S; Babic N; Misiuk-Hojlo M; Mikropoulos DG; Kaluzny BJ; Kozobolis V
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 493-498
